Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Con...
| Metric Name | Value | Trend | |
|---|---|---|---|
| Dividend Yield | 4.3% | ||
| P/E Ratio | -22.3x | ||
| Revenue | 4.373 B | ||
| Net Income to Company | -171.8 M |
| PRGO | Peers | Sector | |
|---|---|---|---|
Market Cap | 3.671 B | 7.656 B | 62.454 M |
Price % of 52 Week High | 78.0% | 58.1% | 61.1% |
Dividend Yield | 4.3% | 3.6% | 0.0% |
Shareholder Yield | 16.4% | 4.5% | -0.7% |
1 Year Price Total Return | -11.0% | 14.1% | -13.2% |
Beta (5 Year) | 0.49 | 0.63 | 0.64 |
| (presentment in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 4,452 | 4,656 | 4,373 | 1,157 | 1,138 |
| Operating Income | 193 | 289 | 417 | 94 | 269 |
| Net Profit | (141) | (13) | (172) | (32) | (45) |
| Diluted EPS | -0.97 | -0.033 | -1.17 | -0.20 | -0.30 |
| EBITDA | 532 | 649 | 743 | 180 | 349 |
| Balance Sheet | |||||
| Cash & ST Invest. | 604 | 744 | 559 | 744 | 559 |
| Current Assets | 2,720 | 2,833 | 2,482 | 2,833 | 2,482 |
| Total Assets | 11,017 | 10,809 | 9,648 | 10,809 | 9,648 |
| Current Liabilities | 1,114 | 1,586 | 1,044 | 1,586 | 1,044 |
| Total Liabilities | 6,175 | 6,041 | 5,328 | 6,041 | 5,328 |
| Total Equity | 4,842 | 4,768 | 4,319 | 4,768 | 4,319 |
| Total Debt | 4,325 | 4,272 | 3,822 | 4,272 | 3,822 |
| Cash Flow Statement | |||||
| Cash Flow Operations | 307 | 406 | 363 | 209 | 313 |
| Cash From Investing | (1,959) | (78) | 79 | (23) | (37) |
| Cash From Financing | 422 | (187) | (611) | (45) | (1,154) |
| Free Cash Flow | 211 | 304 | 231 | 182 | 262 |